Implications of enterotoxigenic Escherichia coli genomics for vaccine development

Expert Review of Vaccines

Volumn 14, Issue 4, 2015, Pages 551-560

  Sjöling, Åsa ^a,b   Von Mentzer, Astrid ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

colonization factor; enterotoxigenic Escherichia coli; ETEC; ETEC vaccine; genomics; next generation sequencing; oral vaccine

Indexed keywords

ANTIGEN; BACTERIAL TOXIN; VACCINE; VIRULENCE FACTOR; ESCHERICHIA COLI VACCINE;

BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL STRAIN; ENTEROTOXIGENIC ESCHERICHIA COLI; GENOMICS; HIGH THROUGHPUT SEQUENCING; IMMUNE RESPONSE; IMMUNITY; NEXT GENERATION SEQUENCING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SUBTRACTIVE HYBRIDIZATION; DRUG DEVELOPMENT; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; TRENDS;

DRUG DISCOVERY; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI VACCINES; GENOMICS; HUMANS;

EID: 84924420948     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2015.996553     Document Type: Review

References (80)

1. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013;382(9888): 209-22
2. Begum YA, Baby NI, Faruque AS, et al. Shift in phenotypic characteristics of enterotoxigenic Escherichia coli (ETEC) isolated from diarrheal patients in Bangladesh. PLOS Neglected Trop Dis 2014;8(7):e3031
3. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005;18:465-83.
4. Black RE, Brown KH, Becker S. Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics 1984;73(6): 799-805
5. Mondal D, Minak J, Alam M, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2012;54(2): 185-92
6. Lamberti LM, Bourgeois AL, Fischer Walker CL, et al. Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and Africa. PLoS Negl Trop Dis 2014;8(2):e2705
7. Macdonald E, Møller KE, Wester AL, et al. An outbreak of enterotoxigenic (ETEC) infection in Norway, 2012: a reminder to consider uncommon pathogens in outbreaks involving imported products. Epidemiol Infect 2014;9:1-8
8. Bölin I, Wiklund G, Qadri F, et al. Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelers. J Clin Microbiol 2006;44:3872-7
9. Isidean SD, Riddle MS, Savarino SJ, Porter CK. Systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine 2011;29:6167-78
10. Qadri F, Das SK, Faruque AS, et al. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol 2000;38(1):27-31
11. Albert MJ, Faruque SM, Faruque AS, et al. Controlled study of Escherichia coli diarrheal infections in Bangladeshi children. J Clin Microbiol 1995;33(4):973-7
12. Levine MM, Ferreccio C, Prado V, et al. Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile. Am J Epidemiol 1993;138(10): 849-69
13. Viboud GI, Jouve MJ, Binsztein N, et al. Prospective cohort study of enterotoxigenic Escherichia coli infections in Argentinean children. J Clin Microbiol 1999;37:2829-33
14. Rodas C, Mamani R, Blanco J, et al. Enterotoxins, colonization factors, serotypes and antimicrobial resistance of enterotoxigenic Escherichia coli (ETEC) strains isolated from hospitalized children with diarrhoea in Bolivia. Braz J Infect Dis 2011;15:132-7
15. Rodas C, Klena J, Nicklasson M, et al. Clonal relatedness in enterotoxigenic Escherichia coli strains expressing LT and CS17 isolated from children with diarrhea in La Paz, Bolivia. PLoS One 2011;6(11): e18313
16. Gonzales L, Sanchez S, Zambrana S, et al. Molecular characterization of enterotoxigenic Escherichia coli isolates recovered from children with diarrhea during a 4-year period (2007 to 2010) in Bolivia. J Clin Microbiol 2013;51:1219-25
17. Harris AM, Chowdhury F, Begum YA, et al. Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am J Trop Med Hyg 2008;79:708-14
18. Torres O, González W, Lemus O, et al. Toxins and virulence factors of enterotoxigenic E. coli (ETEC) associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala. Epidemiol Infect 2014;19:1-10
19. Svennerholm A-M, Lundgren A. Recent progress towards an enterotoxigenic Escherichia coli (ETEC) vaccine Expert Rev Vaccines. 2012;11:495-507
20. Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol 1996;4: 444-52.
21. Sjöling Å, Wiklund G, Savarino SJ, et al. Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors. J Clin Microbiol 2007;45:3295-301
22. López-Vidal Y, Calva JJ, Trujillo A, et al. Enterotoxins and adhesins of enterotoxigenic Escherichia coli: are they risk factors for acute diarrhea in the community? J Infect Dis 1990;162(2):442-7
23. Qadri F, Saha A, Ahmed T, et al. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 2007;75:3961-8
24. Black RE. Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev Infect Dis 1990; 12(Suppl 1):S73-9
25. von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000;356(9224):133-4
26. Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res 2011;133:188-96
27. Lasaro MA, Rodrigues JF, Mathias-Santos C, et al. Genetic diversity of heat-labile toxin expressed by enterotoxigenic Escherichia coli strains isolated from humans. J Bacteriol 2008;190(7):2400-10
28. Joffré E, von Mentzer A, Abd El Ghany M, et al. Allele variants of enterotoxigenic Escherichia coli heat labile toxin are globally transmitted and associated with colonization factors. J Bacteriol 2015;197:2
29. Clemens JD, Sack DA, Harris JR, et al. Cross-protection by B subunit whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 1988; 158(2):372-7
30. Peltola H, Siitonen A, Kyrönseppä H, et al. Prevention of travellers' diarrhoea by oral Bsubunit/whole-cell cholera vaccine. Lancet 1991;338(8778):1285-9
31. Lebens M, Shahabi V, Bäckström M, et al. Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine. Infect Immun 1996;64(6):2144-50
32. Braga CJ, Rodrigues JF, Medina-Armenteros Y, et al. Parenteral adjuvant effects of an enterotoxigenic Escherichia coli natural heat-labile toxin variant. Front Immunol 2014;7(4):487
33. Norton EB, Lawson LB, Freytag LC, Clements JD. Characterization of a mutant Escherichia coli heat-labile toxin, LT (R192G/L211A), as a safe and effective oral adjuvant. Clin Vaccine Immunol 2011; 18(4):546-51.
34. El-Kamary SS, Cohen MB, Bourgeois AL. Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli. Clin Vaccine Immunol 2013;20(11):1764-70
35. Lundgren A, Adamsson J, Bourgeois L, et al. Safety and immunogenicity of an improved oral, inactivated, multivalent Escherichia coli (ETEC) vaccine administered alone or together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine 2014. [Epub ahead of print].
36. Holmgren J, Bourgeois L, Carlin N, et al. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine 2013;31(20):2457-64
37. Takeda T, Nair GB, Suzuki K, et al. Epitope mapping and characterization of antigenic determinants of heat-stable enterotoxin (STh) of enterotoxigenic Escherichia coli by using monoclonal antibodies. Infect Immun 1993;61(1): 289-94
38. Svennerholm A-M, Wikström M, Lindblad M, Holmgren J. Monoclonal antibodies against E. coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24:585-90
39. Ruan X, Robertson DC, Nataro JP, et al. Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies. Infect Immun 2014;82(5):1823-32
40. Taxt AM, Diaz Y, Bacle A, et al. Characterization of Immunological Cross-Reactivity between Enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin. Infect Immun 2014;82(7):2913-22
41. McKenzie R, Bourgeois AL, Frech SA, et al. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine 2007;25(18): 3684-91
42. Nuccio SP, Bäumler AJ. Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek. Microbiol Mol Biol Rev 2007;71(4):551-75
43. Nicklasson M, Sjöling Å, von Mentzer A, et al. Expression of colonization factor cs5 of enterotoxigenic Escherichia coli (ETEC) Is enhanced in vivo and by the bile component Na glycocholate hydrate. PLoS One 2012;7(4):e35827
44. Munson GP. Virulence regulons of enterotoxigenic Escherichia coli. Immunol Res 2013;57:229-36
45. Anantha RP, McVeigh AL, Lee LH, et al. Evolutionary and functional relationships of colonization factor antigen I and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli. Infect Immun 2004;72: 7190-201.
46. Nada RA, Shaheen HI, Khalil SB, et al. Discovery and phylogenetic analysis of novel members of class b enterotoxigenic Escherichia coli Adhesive Fimbriae. J Clin Microbiol 2011;49:1403-10
47. Del Canto F, Botkin DJ, Valenzuela P, et al. Identification of Coli surface antigen 23, a novel adhesin of enterotoxigenic Escherichia coli. Infect Immun 2012;80(8): 2791-801
48. Pichel M, Binsztein N, Viboud G. CS22, a novel human enterotoxigenic Escherichia coli adhesin, is related to CS15. Infect Immun 2000;68:3280-5
49. Rudin A, McConnell MM, Svennerholm AM. Monoclonal antibodies against enterotoxigenic Escherichia coli colonization factor antigen I (CFA/I) that cross-react immunologically with heterologous CFAs. Infect Immun 1994; 62(10):4339-46
50. Qadri F, Ahmed F, Ahmed T, Svennerholm AM. Homologous and cross-reactive immune responses to enterotoxigenic Escherichia coli colonization factors in Bangladeshi children. Infect Immun 2006;74(8):4512-18.
51. Guiterrez R, Riddle M, Porter C, et al. Phase I clinical evaluation of adhesion-based ETEC vaccines. Vaccines for Enteric Diseases meeting abstract Bangkok, November 2013
52. von Mentzer A, Connor T, Wieler LH, et al. Identification of Enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution. Nat Genet 2014;46(12):1321-6.
53. Fleckenstein JM, Kopecko DJ, Warren RL, Elsinghorst EA. Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli. Infect Immun 1996;64(6):2256-65
54. Elsinghorst EA, Weitz JA. Epithelial cell invasion and adherence directed by the enterotoxigenic Escherichia coli tib locus is associated with a 104-kilodalton outer membrane protein. Infect Immun 1994; 62(8):3463-71
55. Pilonieta MC, Bodero MD, Munson GP. CfaD-dependent expression of a novel extracytoplasmic protein from enterotoxigenic Escherichia coli. J Bacteriol 2007;189(14):5060-7
56. Fleckenstein JM, Roy K, Fischer JF, Burkitt M. Identification of a two-partner secretion locus of enterotoxigenic Escherichia coli. Infect Immun 2006;74: 2245-58
57. Roy K, Hilliard GM, Hamilton DJ, et al. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature 2009;457:594-8
58. Roy K, Hamilton DJ, Munson GP, Fleckenstein JM. Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli. Clin Vaccine Immunol 2011(11):1803-8
59. Patel SK, Dotson J, Allen KP, Fleckenstein JM. Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli. Infect Immun 2004;72: 1786-94
60. Kumar P, Luo Q, Vickers TJ, et al. EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin. Infect Immun 2014;82(2): 500-8
61. Luo Q, Kumar P, Vickers TJ, et al. Enterotoxigenic Escherichia coli secretes a highly conserved mucin-degrading metalloprotease to effectively engage intestinal epithelial cells. Infect Immun 2014;82(2):509-21
62. Darsley MJ, Chakraborty S, DeNearing B, et al. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol 2012;19(12):1921-31.
63. Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000;287:1816-20.
64. Rappuoli R. Reverse vaccinology. Curr Opin Microbiol 2000;3:445-50
65. Maione D, Margarit I, Rinaudo CD, et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 2005;309:148-50
66. Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci U S A 2010; 107(20):9072-7.
67. Seib KL, Zhao X, Rappuoli R. Developing vaccines in the era of genomics: a decade of reverse vaccinology. Clin Microbiol Infect 2012;18(5):109-16
68. Nesta B, Spraggon G, Alteri C, et al. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio 2012;3:2
69. Chen Q, Savarino SJ, Venkatesan MM. Subtractive hybridization and optical mapping of the enterotoxigenic Escherichia coli H10407 chromosome: isolation of unique sequences and demonstration of significant similarity to the chromosome of E. coli K-12. Microbiology 2006;152: 1041-54
70. Ouyang Z, Isaacson R. Identification and characterization of a novel ABC iron transport system, fit, in Escherichia coli. Infect Immun 2006;74:6949-56
71. Touchon M, Hoede C, Tenaillion O, et al. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 2009;5: e1000344
72. Rasko DA, Rosovitz MJ, Myers GS, et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 2008;190(20):6881-93.
73. Crossman LC, Chaudhuri RR, Beatson SA, et al. A commensal gone bad: complete genome sequence of the prototypical enterotoxigenic strain H10407. J Bacteriol 2010;192(21):5822-31.
74. Sahl JW, Steinsland H, Redman JC, et al. A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation. Infect Immun 2011;79(2):950-60
75. Madhavan TP, Steen JA, Hugenholtz P, Sakellaris H. Genome Sequence of Enterotoxigenic Escherichia coli Strain B2C. Genome Announc 2014;2(2):e00247-14
76. Kansal R, Rasko DA, Sahl JW, et al. Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions. Infect Immun 2013;81(1): 259-70
77. Baldi DL, Higginson EE, Hocking DM, et al. The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli. Infect Immun 2012;80(6):2042-52
78. Nesta B, Valeri M, Spagnuolo A, et al. SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains. PLoS Pathog 2014;10(5):e1004124
79. Moriel DG, Rosini R, Seib KL, et al. Escherichia coli: great diversity around a common core. MBio 2012;3(3): pii: e00118-12
80. Decanio MS, Landick R, Haft RJ. The non-pathogenic Escherichia coli strain W secretes SslE via the virulence-associated type II secretion system beta. BMC Microbiol 2012;13:130